CONMED Corporation (CNMD)

Financial leverage ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total assets	US$ in thousands	2,306,250	2,300,020	2,297,590	1,766,020	1,751,670
Total stockholders’ equity	US$ in thousands	962,681	834,222	745,545	785,435	709,038
Financial leverage ratio		2.40	2.76	3.08	2.25	2.47

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,306,250K ÷ $962,681K
= 2.40

The financial leverage ratio of CONMED Corporation has displayed some fluctuations over the past five years. The ratio was 2.47 as of December 31, 2020, indicating that for every dollar of equity, the company had $2.47 of debt. Over the subsequent years, the ratio decreased to 2.25 by December 31, 2021, suggesting a reduction in the level of debt relative to equity.

However, a significant shift occurred by December 31, 2022, where the financial leverage ratio spiked to 3.08, reflecting a higher proportion of debt in the company's capital structure. This increase may raise concerns about the company's financial risk and ability to meet its debt obligations.

By December 31, 2023, the ratio slightly declined to 2.76, indicating a moderate improvement in the debt-to-equity mix. Finally, as of December 31, 2024, the financial leverage ratio stood at 2.40, indicating a more moderate level of debt compared to equity.

Overall, the trend in CONMED Corporation's financial leverage ratio suggests some variation in the company's capital structure and debt management over the analyzed period. Investors and stakeholders may monitor these changes to assess the company's risk profile and financial stability.